ORPHELIA Pharma will be present in Paris on November, 5th and 6th, for the Rare Diseases Meeting Days. This event is organized by the French Foundation for Rare Diseases every other year, and allows to assist during two days to plenary conferences and scientific round tables on current topics, poster presentations and meetings with researchers, meeting with companies and stakeholders of the sector.
The organizing committee of the Foundation selected ORPHELIA’s poster entitled “Multicentre retrospective study of temozolomide use in paediatric refractory or relapsed neuroblastoma : Results from analysis of data from French centres”, to be presented during the Rare Diseases Meeting Days.
Do not hesitate to contact us in order to meet at this occasion (hugues.bienayme@orphelia-pharma.eu).